Faculty Opinions recommendation of Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons.

2012 ◽  
Author(s):  
Hans Peter Volz
Keyword(s):  
Systematic Review ◽  
Side Effects ◽  
Antipsychotic Drugs ◽  
Second Generation ◽  
Meta Analysis ◽  
Extrapyramidal Side Effects ◽  
Second Generation Antipsychotic

scholarly journals Second-Generation Antipsychotic Drugs and Extrapyramidal Side Effects: A Systematic Review and Meta-analysis of Head-to-Head Comparisons

2010 ◽  
Vol 38 (1) ◽  
pp. 167-177 ◽  
Author(s):  
Christine Rummel-Kluge ◽  
Katja Komossa ◽  
Sandra Schwarz ◽  
Heike Hunger ◽  
Franziska Schmid ◽  
...  
Keyword(s):  
Systematic Review ◽  
Side Effects ◽  
Antipsychotic Drugs ◽  
Second Generation ◽  
Meta Analysis ◽  
Extrapyramidal Side Effects ◽  
Second Generation Antipsychotic

scholarly journals Second-generation antipsychotic drugs and short-term somatic serious adverse events: a systematic review and meta-analysis

2019 ◽  
Vol 6 (9) ◽  
pp. 753-765 ◽  
Author(s):  
Johannes Schneider-Thoma ◽  
Orestis Efthimiou ◽  
Irene Bighelli ◽  
Carola Dörries ◽  
Maximilian Huhn ◽  
...  
Keyword(s):  
Systematic Review ◽  
Adverse Events ◽  
Antipsychotic Drugs ◽  
Second Generation ◽  
Meta Analysis ◽  
Short Term ◽  
Serious Adverse Events ◽  
Second Generation Antipsychotic

Quetiapine-induced cervical dystonia

2015 ◽  
Vol 26 (3) ◽  
pp. 311-312 ◽  
Author(s):  
Grace Tso ◽  
Uday Kolur
Keyword(s):  
Side Effects ◽  
Cervical Dystonia ◽  
Second Generation ◽  
Risk Profile ◽  
Extrapyramidal Side Effects ◽  
Second Generation Antipsychotic

Objective: Our objective was to report and describe a case of quetiapine-induced dystonia in an older lady with psychosis. Quetiapine is a second-generation antipsychotic and known to be rare in causing extrapyramidal side effects with rates similar to placebo. Conclusions: There have been few documented cases of quetiapine-induced dystonia. It is important to be vigilant and consider the development of dystonia in patients who may not fit the typical risk profile.

scholarly journals Metabolic Side-Effects of the Novel Second-Generation Antipsychotic Drugs Asenapine and Iloperidone: A Comparison with Olanzapine

PLoS ONE ◽  
2013 ◽  
Vol 8 (1) ◽  
pp. e53459 ◽  
Author(s):  
Heidi N. Boyda ◽  
Ric M. Procyshyn ◽  
Catherine C. Y. Pang ◽  
Erin Hawkes ◽  
Daniel Wong ◽  
...  
Keyword(s):  
Side Effects ◽  
Antipsychotic Drugs ◽  
Second Generation ◽  
The Novel ◽  
Metabolic Side Effects ◽  
Second Generation Antipsychotic

Risk of extrapyramidal side effects comparing continuous vs. bolus intravenous metoclopramide administration: a systematic review and meta-analysis of randomised controlled trials

2015 ◽  
Vol 24 (23-24) ◽  
pp. 3638-3646 ◽  
Author(s):  
Iván Cavero-Redondo ◽  
Celia Álvarez-Bueno ◽  
Diana P Pozuelo-Carrascosa ◽  
Ana Díez-Fernández ◽  
Blanca Notario-Pacheco
Keyword(s):  
Systematic Review ◽  
Side Effects ◽  
Randomised Controlled Trials ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Extrapyramidal Side Effects ◽  
Randomised Controlled
Sign in / Sign up

Export Citation Format

Share Document